Prelude Capital Management’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,501
Closed -$1K 1672
2022
Q3
$1K Hold
13,501
﹤0.01% 1418
2022
Q2
$1K Hold
13,501
﹤0.01% 1539
2022
Q1
$3K Sell
13,501
-5,000
-27% -$1.11K ﹤0.01% 1416
2021
Q4
$10K Buy
18,501
+400
+2% +$216 ﹤0.01% 1512
2021
Q3
$11K Buy
18,101
+400
+2% +$243 ﹤0.01% 1262
2021
Q2
$13K Buy
+17,701
New +$13K ﹤0.01% 1288